scholarly journals SPETTROSCOPIA E IMAGING IN OTTICA DIFFUSA: FOCUS SUL TUMORE DELLA MAMMELLA

2020 ◽  
Author(s):  
Paola Taroni
Keyword(s):  
Breast Cancer ◽  
Near Infrared ◽  
Breast Cancer Diagnosis ◽  
Biological Tissues ◽  
Blood Parameters ◽  
Collagen Content ◽  
Diffuse Optics ◽  
Non Invasive ◽  
Ultrasound Diagnostics

Through the measurement of the optical properties (absorption and scattering), diffuse optical spectroscopy allows one to estimate non-invasively the composition of biological tissues (water, lipid and collagen content) and functional blood parameters. Further, it provides information on the microscopic tissue structure. It can therefore be effectively used in vivo as an absolutely non-invasive diagnostic tool. The Department of Physics of the Politecnico di Milano has designed and built an optical mammograph that exploits diffused optics, operating with pulsed light at 7 wavelengths in the red and near infrared spectral range (635-1060 nm). The instrument was used in a clinical study on 200 subjects, in collaboration with the European Institute of Oncology: optically derived tissue composition and in particular collagen content in tissues proved to be effective both to discriminate between malignant and benign breast lesions, and to estimate the risk of breast cancer related to the density of breast tissue, which is recognized among the most important independent risk factors. Partly based on those results, “SOLUS - Smart optical and ultrasound diagnostics of breast cancer”, a European project in the H2020 Framework Program, is now working to improve the specificity of non-invasive breast cancer diagnosis by combining diffuse optics with ultrasound imaging.

scholarly journals Development of a handheld diffuse optical breast cancer assessment probe

2016 ◽  
Vol 09 (02) ◽  
pp. 1650007 ◽  
Author(s):  
Majid Shokoufi ◽  
Farid Golnaraghi
Keyword(s):  
Breast Cancer ◽  
Optical Properties ◽  
Breast Tissue ◽  
Near Infrared ◽  
Human Subjects ◽  
Breast Cancer Diagnosis ◽  
Functional Brain Imaging ◽  
Wide Range ◽  
Concentration Changes

Diffuse Optical Spectroscopy (DOS) is a promising non-invasive and non-ionizing technique for breast anomaly detection. In this study, we have developed a new handheld DOS probe to measure optical properties of breast tissue. In the proposed probe, the breast tissue is illuminated with four near infrared (NIR) wavelengths light emitting diodes (LED), which are encapsulated in a package (eLEDs), and two PIN photodiodes measure the intensity of the scattered photons at two different locations. The proposed technique of using eLEDs is introduced, in order to have a multi-wavelength pointed-beam illumination source instead of using the laser-coupled fiber-optic technique, which increases the complexity, size, and cost of the probe. Despite the fact that the proposed technique miniaturizes the probe and reduces the complexity of the DOS, the study proves that it is accurate and reliable in measuring optical properties of the tissue. The measurements are performed at the rate of 10[Formula: see text]Hz which is suitable for dynamic measurement of biological activity, in-vivo. The multi-spectral evaluation algorithm is used to reconstruct four main absorber concentrations in the breast including oxy-hemoglobin (cHb), deoxy-hemoglobin (cHbO2), water (cH2O), fat (cFat), and average scattering coefficient of the medium, as well as concentration changes in Hb ([Formula: see text]cHb) and HbO2 ([Formula: see text]cHbO2). Although the probe is designed for breast cancer diagnosis, it can be used in a wide range of applications for both static and dynamic measurements such as functional brain imaging. A series of phantoms, comprised of Delrin[Formula: see text], Intralipid[Formula: see text], PierceTM and Black ink, are used to verify performance of the device. The probe will be tested on human subjects, in-vivo, in the next phase.

scholarly journals Non-Invasive In Vivo Imaging of Near Infrared-labeled Transferrin in Breast Cancer Cells and Tumors Using Fluorescence Lifetime FRET

PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e80269 ◽  
Author(s):  
Ken Abe ◽  
Lingling Zhao ◽  
Ammasi Periasamy ◽  
Xavier Intes ◽  
Margarida Barroso
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Fluorescence Lifetime ◽  
In Vivo Imaging ◽  
Breast Cancer Cells ◽  
Near Infrared ◽  
Non Invasive

scholarly journals Applications of Vibrational Spectroscopy for Analysis of Connective Tissues

Molecules ◽  
2021 ◽  
Vol 26 (4) ◽  
pp. 922
Author(s):  
William Querido ◽  
Shital Kandel ◽  
Nancy Pleshko
Keyword(s):  
Raman Spectroscopy ◽  
Vibrational Spectroscopy ◽  
Near Infrared ◽  
Ex Vivo ◽  
Biological Tissues ◽  
Label Free ◽  
Connective Tissues ◽  
Bone Properties ◽  
Composition And Structure

Advances in vibrational spectroscopy have propelled new insights into the molecular composition and structure of biological tissues. In this review, we discuss common modalities and techniques of vibrational spectroscopy, and present key examples to illustrate how they have been applied to enrich the assessment of connective tissues. In particular, we focus on applications of Fourier transform infrared (FTIR), near infrared (NIR) and Raman spectroscopy to assess cartilage and bone properties. We present strengths and limitations of each approach and discuss how the combination of spectrometers with microscopes (hyperspectral imaging) and fiber optic probes have greatly advanced their biomedical applications. We show how these modalities may be used to evaluate virtually any type of sample (ex vivo, in situ or in vivo) and how “spectral fingerprints” can be interpreted to quantify outcomes related to tissue composition and quality. We highlight the unparalleled advantage of vibrational spectroscopy as a label-free and often nondestructive approach to assess properties of the extracellular matrix (ECM) associated with normal, developing, aging, pathological and treated tissues. We believe this review will assist readers not only in better understanding applications of FTIR, NIR and Raman spectroscopy, but also in implementing these approaches for their own research projects.

scholarly journals Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cancer

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Liping Huang ◽  
Yiyi Zhang ◽  
Yanan Li ◽  
Fanling Meng ◽  
Hongyu Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Near Infrared ◽  
Immune Escape ◽  
Regulatory Protein ◽  
In Vivo Studies ◽  
Breast Cancer Patients ◽  
Thermally Responsive ◽  
Immunosuppressive Microenvironment

AbstractThe highly immunosuppressive microenvironment after surgery has a crucial impact on the recurrence and metastasis in breast cancer patients. Programmable delivery of immunotherapy-involving combinations through a single drug delivery system is highly promising, yet greatly challenging, to reverse postoperative immunosuppression. Here, an injectable hierarchical gel matrix, composed of dual lipid gel (DLG) layers with different soybean phosphatidylcholine/glycerol dioleate mass ratios, was developed to achieve the time-programmed sequential delivery of combined cancer immunotherapy. The outer layer of the DLG matrix was thermally responsive and loaded with sorafenib-adsorbed graphene oxide (GO) nanoparticles. GO under manually controlled near-infrared irradiation generated mild heat and provoked the release of sorafenib first to reeducate tumor-associated macrophages (TAMs) and promote an immunogenic tumor microenvironment. The inner layer, loaded with anti-CD47 antibody (aCD47), could maintain the gel state for a much longer time, enabling the sustained release of aCD47 afterward to block the CD47-signal regulatory protein α (SIRPα) pathway for a long-term antitumor effect. In vivo studies on 4T1 tumor-bearing mouse model demonstrated that the DLG-based strategy efficiently prevented tumor recurrence and metastasis by locally reversing the immunosuppression and synergistically blocking the CD47-dependent immune escape, thereby boosting the systemic immune responses.

scholarly journals Non-invasive, real-time reporting drug release in vitro and in vivo

2015 ◽  
Vol 51 (32) ◽  
pp. 6948-6951 ◽  
Author(s):  
Yanfeng Zhang ◽  
Qian Yin ◽  
Jonathan Yen ◽  
Joanne Li ◽  
Hanze Ying ◽  
...  
Keyword(s):  
Drug Release ◽  
Real Time ◽  
Near Infrared ◽  
Reporting System ◽  
Real Time Monitoring ◽  
Near Infrared Fluorescence ◽  
Non Invasive ◽  
Fluorescence Dye

Anin vitroandin vivodrug-reporting system is developed for real-time monitoring of drug release via the analysis of the concurrently released near-infrared fluorescence dye.

scholarly journals Imaging of β-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience

2015 ◽  
Vol 44 (7) ◽  
pp. 1807-1819 ◽  
Author(s):  
Matteo Staderini ◽  
María Antonia Martín ◽  
Maria Laura Bolognesi ◽  
J. Carlos Menéndez
Keyword(s):  
Near Infrared ◽  
Amyloid Plaques ◽  
Fluorescent Tracers ◽  
Non Invasive ◽  
Nir Imaging ◽  
New Frontier ◽  
Invasive Method ◽  
Β Amyloid

Near infrared (NIR) imaging is a promising and non-invasive method to visualize amyloid plaquesin vivo.

scholarly journals Multiplexed Non-invasive in vivo Imaging to Assess Metabolism and Receptor Engagement in Tumor Xenografts

2019 ◽  
Author(s):  
Alena Rudkouskaya ◽  
Nattawut Sinsuebphon ◽  
Marien Ochoa ◽  
Joe E. Mazurkiewicz ◽  
Xavier Intes ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Targeted Delivery ◽  
Near Infrared ◽  
Metabolic Response ◽  
Imaging Modalities ◽  
Wide Field ◽  
Receptor Ligand ◽  
Non Invasive ◽  
Intracellular Drug Delivery

AbstractFollowing an ever-increased focus on personalized medicine, there is a continuing need to develop preclinical molecular imaging modalities to guide the development and optimization of targeted therapies. To date, non-invasive quantitative imaging modalities that can comprehensively assess simultaneous cellular drug delivery efficacy and therapeutic response are lacking. In this regard, Near-Infrared (NIR) Macroscopic Fluorescence Lifetime Förster Resonance Energy Transfer (MFLI-FRET) imaging offers a unique method to robustly quantify receptor-ligand engagement in vivo and subsequent intracellular internalization, which is critical to assess the delivery efficacy of targeted therapeutics. However, implementation of multiplexing optical imaging with FRET in vivo is challenging to achieve due to spectral crowding and cross-contamination. Herein, we report on a strategy that relies on a dark quencher that enables simultaneous assessment of receptor-ligand engagement and tumor metabolism in intact live mice. First, we establish that IRDye QC-1 (QC-1) is an effective NIR dark acceptor for the FRET-induced quenching of donor Alexa Fluor 700 (AF700) using in vitro NIR FLI microscopy and in vivo wide-field MFLI imaging. Second, we report on simultaneous in vivo imaging of the metabolic probe IRDye 800CW 2-deoxyglucose (2-DG) and MFLI-FRET imaging of NIR-labeled transferrin FRET pair (Tf-AF700/Tf-QC-1) uptake in tumors. Such multiplexed imaging revealed an inverse relationship between 2-DG uptake and Tf intracellular delivery, suggesting that 2-DG signal may predict the efficacy of intracellular targeted delivery. Overall, our methodology enables for the first time simultaneous non-invasive monitoring of intracellular drug delivery and metabolic response in preclinical studies.

Identification of non-invasive biomarkers for early detection of breast cancer: A Review

2021 ◽  
Vol 2 (1) ◽  
pp. 01-05
Author(s):  
Asima Tayyab
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Potential Role ◽  
Small Volume ◽  
Breast Cancer Diagnosis ◽  
Diagnostic Purpose ◽  
Diagnose Breast Cancer ◽  
Non Invasive ◽  
Early Stages

Despite decades of research, diagnostic tests with specificity and accuracy for early breast cancer are yet unavailable. Major problems associated with poor diagnosis are either due to incompetency of reported biomarkers or small volume of patients under study. Moreover, heterogeneity of the disease further complicates the struggle of identifying effective biomarkers. Therefore, to improve the survival rate, look for new, sensitive and specific biomarkers for early breast cancer diagnosis is need of hour. In this study, we have reviewed recently reported serum biomarkers and categorized them based on their biomolecular nature such as protein, ctDNA, epigenetics regulation and miRNA. Potential role of these available biomarkers in early diagnosis of breast cancer has also been discussed. Based on the facts obtained from literature review, it is revealed that using any individual biomolecule as a biomarker is not sufficient to diagnose breast cancer at early stages rather it is suggested that a panel of proteins or miRNAs would offer better sensitivity and specificity. Whereas, unavailability of a potential ctDNA and epigenetics regulation candidate for diagnostic purpose is and suggest the use of more sophisticated techniques to unwound these regulations in serum especially at early stages of breast cancer.

scholarly journals Handheld diffuse optical breast scanner probe for cross-sectional imaging of breast tissue

2019 ◽  
Vol 12 (02) ◽  
pp. 1950008 ◽  
Author(s):  
Majid Shokoufi ◽  
Farid Golnaraghi
Keyword(s):  
Breast Cancer ◽  
Breast Imaging ◽  
Breast Tissue ◽  
Reconstruction Algorithm ◽  
Breast Cancer Diagnosis ◽  
Array Detector ◽  
Light Sources ◽  
Compact Structure ◽  
Cross Sectional

Diffuse optical spectroscopy is a relatively new, noninvasive and nonionizing technique for breast cancer diagnosis. In the present study, we have introduced a novel handheld diffuse optical breast scan (DOB-Scan) probe to measure optical properties of the breast in vivo and create functional and compositional images of the tissue. In addition, the probe gives more information about breast tissue’s constituents, which helps distinguish a healthy and cancerous tissue. Two symmetrical light sources, each including four different wavelengths, are used to illuminate the breast tissue. A high-resolution linear array detector measures the intensity of the back-scattered photons at different radial destinations from the illumination sources on the surface of the breast tissue, and a unique image reconstruction algorithm is used to create four cross-sectional images for four different wavelengths. Different from fiber optic-based illumination techniques, the proposed method in this paper integrates multi-wavelength light-emitting diodes to act as pencil beam sources into a scattering medium like breast tissue. This unique design and its compact structure reduce the complexity, size and cost of a potential probe. Although the introduced technique miniaturizes the probe, this study points to the reliability of this technique in the phantom study and clinical breast imaging. We have received ethical approval to test the DOB-Scan probe on patients and we are currently testing the DOB-Scan probe on subjects who are diagnosed with breast cancer.

scholarly journals In vivo non-invasive near-infrared spectroscopy distinguishes normal, post-stroke, and botulinum toxin treated human muscles

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Antonio Currà ◽  
Riccardo Gasbarrone ◽  
Alessandra Cardillo ◽  
Francesco Fattapposta ◽  
Paolo Missori ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Near Infrared ◽  
Comprehensive Evaluation ◽  
Botulinum Toxin Injection ◽  
Principal Component ◽  
Short Wave ◽  
Post Stroke ◽  
Non Invasive ◽  
Optimal Monitoring

AbstractIn post-stroke hemiparesis, neural impairment alters muscle control, causing abnormal movement and posture in the affected limbs. A decrease in voluntary use of the paretic arm and flexed posture during rest also induce secondary tissue transformation in the upper limb muscles. To obtain a specific, accurate, and reproducible marker of the current biological status of muscles, we collected visible (VIS) and short-wave Infrared (SWIR) reflectance spectra in vivo using a portable spectroradiometer (350–2500 nm), which provided the spectral fingerprints of the elbow flexors and extensors. We compared the spectra for the affected and unaffected sides in 23 patients with post-stroke hemiparesis (25–87 years, 8 women) and eight healthy controls (33–87 years, 5 women). In eight patients, spectra were collected before and after botulinum toxin injection. Spectra underwent off-line preprocessing, principal component analysis, and partial least-squares discriminant analysis. Spectral fingerprints discriminated the muscle (biceps vs. triceps), neurological condition (normal vs. affected vs. unaffected), and effect of botulinum toxin treatment (before vs. 30 to 40 days vs. 110 to 120 days after injection). VIS-SWIR spectroscopy proved valuable for non-invasive assessment of optical properties in muscles, enabled more comprehensive evaluation of hemiparetic muscles, and provided optimal monitoring of the effectiveness of medication.

Sign in / Sign up

Export Citation Format

Share Document